The work offers a proof of concept for the notion that dynamic models of signaling could serve as more effective biomarkers than discrete molecular markers.
The proof-of-principle application suggests networks of microRNA, RNA, and other 'omics data can untangle drug response and more.
The firms are integrating their technology platforms for drug discovery applications.
Webb Miller, Trey Ideker, Patrick Soon-Shiong
Now in its ninth year, the experiment that was the Institute for Systems Biology has become an established research organization known for its focus on translational science.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.